Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Heparin or heparan sulfate--what is the difference?

Literature DB >> 1926051

Heparin or heparan sulfate--what is the difference?

U Lindahl, L Kjellén.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 1991 PMID： 1926051

Source DB: PubMed Journal: Thromb Haemost ISSN： 0340-6245 Impact factor: 5.249

Keyword Cloud
Cited

× No keyword cloud information.

16 in total

1. A chemotactic gradient sequestered on endothelial heparan sulfate induces directional intraluminal crawling of neutrophils.

Authors: Sara Massena; Gustaf Christoffersson; Elina Hjertström; Eyal Zcharia; Israel Vlodavsky; Nora Ausmees; Charlotte Rolny; Jin-Ping Li; Mia Phillipson
Journal: Blood Date: 2010-06-08 Impact factor: 22.113

2. Disaccharides generated from heparan sulphate or heparin modulate chemokine-induced T-cell adhesion to extracellular matrix.

Authors: R Hershkoviz; H Schor; A Ariel; I Hecht; I R Cohen; O Lider; L Cahalon
Journal: Immunology Date: 2000-01 Impact factor: 7.397

3. Brain mast cell relationship to neurovasculature during development.

Authors: Mona Khalil; Jocelyn Ronda; Michael Weintraub; Kim Jain; Rae Silver; Ann-Judith Silverman
Journal: Brain Res Date: 2007-07-26 Impact factor: 3.252

Review 4. Chemoenzymatic synthesis of the next generation of ultralow MW heparin therapeutics.

Authors: Sayaka Masuko; Robert J Linhardt
Journal: Future Med Chem Date: 2012-03 Impact factor: 3.808

Review 5. Glycosaminoglycans and the regulation of blood coagulation.

Authors: M C Bourin; U Lindahl
Journal: Biochem J Date: 1993-01-15 Impact factor: 3.857

6. The Responses of Hyperglycemic Dividing Mesangial Cells to Heparin Are Mediated by the Non-reducing Terminal Trisaccharide.

Authors: Christina P Wang; Vincent C Hascall; Fuming Zhang; Robert J Linhardt; Amina Abbadi; Aimin Wang
Journal: J Biol Chem Date: 2015-09-16 Impact factor: 5.157

7. Differences in the susceptibility of herpes simplex virus types 1 and 2 to modified heparin compounds suggest serotype differences in viral entry.

Authors: B C Herold; S I Gerber; B J Belval; A M Siston; N Shulman
Journal: J Virol Date: 1996-06 Impact factor: 5.103